HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 286/5/E834    most recent 00292.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (22) Citing Articles via Google Scholar Google Scholar Articles by Doliba, N. M. Articles by Matschinsky, F. M. Search for Related Content PubMed PubMed Citation Articles by Doliba, N. M. Articles by Matschinsky, F. M.

Restitution of defective glucose-stimulated insulin release of sulfonylurea type 1 receptor knockout mice by acetylcholine

¹The Diabetes Research Center and Department of Biochemistry and Biophysics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104; ²Pharmacological Research 1, Novo Nordisk, Bagsvaerd, Denmark; and ³Department of Molecular Physiology and Biophysics, Vanderbilt University School of Medicine, Nashville, Tennessee 37232

Submitted 26 June 2003 ; accepted in final form 15 January 2004

Inhibition of ATP-sensitive K⁺ (K_ATP) channels by an increase in the ATP/ADP ratio and the resultant membrane depolarization are considered essential in the process leading to insulin release (IR) from pancreatic -cells stimulated by glucose. It is therefore surprising that mice lacking the sulfonylurea type 1 receptor (SUR1^–/–) in -cells remain euglycemic even though the knockout is expected to cause hypoglycemia. To complicate matters, isolated islets of SUR1^–/– mice secrete little insulin in response to high glucose, which extrapolates to hyperglycemia in the intact animal. It remains thus unexplained how euglycemia is maintained. In recognition of the essential role of neural and endocrine regulation of IR, we evaluated the effects of acetylcholine (ACh) and glucagon-like peptide-1 (GLP-1) on IR and free intracellular Ca²⁺ concentration ([Ca²⁺]_i) of freshly isolated or cultured islets of SUR1^–/– mice and B6D2F1 controls (SUR1^+/+). IBMX, a phosphodiesterase inhibitor, was also used to explore cAMP-dependent signaling in IR. Most striking, and in contrast to controls, SUR1^–/– islets are hypersensitive to ACh and IBMX, as demonstrated by a marked increase of IR even in the absence of glucose. The hypersensitivity to ACh was reproduced in control islets by depolarization with the SUR1 inhibitor glyburide. Pretreatment of perifused SUR1^–/– islets with ACh or IBMX restored glucose stimulation of IR, an effect expectedly insensitive to diazoxide. The calcium channel blocker verapamil reduced but did not abolish ACh-stimulated IR, supporting a role for intracellular Ca²⁺ stores in stimulus-secretion coupling. The effect of ACh on IR was greatly potentiated by GLP-1 (10 nM). ACh caused a dose-dependent increase in [Ca²⁺]_i at 0.1–1 µM or biphasic changes (an initial sharp increase in [Ca²⁺]_i followed by a sustained phase of low [Ca²⁺]_i) at 1–100 µM. The latter effects were observed in substrate-free medium or in the presence of 16.7 mM glucose. We conclude that SUR1 deletion depolarizes the -cells and markedly elevates basal [Ca²⁺]_i. Elevated [Ca²⁺]_i in turn sensitizes the -cells to the secretory effects of ACh and IBMX. Priming by the combination of high [Ca²⁺]_i, ACh, and GLP-1 restores the defective glucose responsiveness, precluding the development of diabetes but not effectively enough to cause hyperinsulinemic hypoglycemia.

calcium

This article has been cited by other articles:

				X. Geng, L. Li, R. Bottino, A. N. Balamurugan, S. Bertera, E. Densmore, A. Su, Y. Chang, M. Trucco, and P. Drain Antidiabetic sulfonylurea stimulates insulin secretion independently of plasma membrane KATP channels Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E293 - E301. [Abstract] [Full Text] [PDF]

				R. L. Sorenson, L. E. Stout, T. C. Brelje, T. L. Jetton, and F. M. Matschinsky Immunohistochemical Evidence for the Presence of Glucokinase in the Gonadotropes and Thyrotropes of the Anterior Pituitary Gland of Rat and Monkey J. Histochem. Cytochem., June 1, 2007; 55(6): 555 - 566. [Abstract] [Full Text] [PDF]

				N. M. Doliba, W. Qin, M. Z. Vatamaniuk, C. W. Buettger, H. W. Collins, M. A Magnuson, K. H. Kaestner, D. F. Wilson, R. D. Carr, and F. M. Matschinsky Cholinergic regulation of fuel-induced hormone secretion and respiration of SUR1-/- mouse islets Am J Physiol Endocrinol Metab, September 1, 2006; 291(3): E525 - E535. [Abstract] [Full Text] [PDF]

				G. Kang, O. G. Chepurny, B. Malester, M. J. Rindler, H. Rehmann, J. L. Bos, F. Schwede, W. A. Coetzee, and G. G. Holz cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic {beta} cells and rat INS-1 cells J. Physiol., June 15, 2006; 573(3): 595 - 609. [Abstract] [Full Text] [PDF]

				F. M. Matschinsky, M. A. Magnuson, D. Zelent, T. L. Jetton, N. Doliba, Y. Han, R. Taub, and J. Grimsby The Network of Glucokinase-Expressing Cells in Glucose Homeostasis and the Potential of Glucokinase Activators for Diabetes Therapy Diabetes, January 1, 2006; 55(1): 1 - 12. [Abstract] [Full Text] [PDF]

				M. S. Remedi, J. C. Koster, B. L. Patton, and C. G. Nichols ATP-Sensitive K+ Channel Signaling in Glucokinase-Deficient Diabetes Diabetes, October 1, 2005; 54(10): 2925 - 2931. [Abstract] [Full Text] [PDF]

				K. Minami, T. Miki, T. Kadowaki, and S. Seino Roles of ATP-Sensitive K+ Channels as Metabolic Sensors: Studies of Kir6.x Null Mice Diabetes, December 1, 2004; 53(suppl_3): S176 - S180. [Abstract] [Full Text] [PDF]